Back to mobile site

Goldman Sachs Upgrades Merck (MRK) to Buy on Pipeline and Keytruda LOE Priced In

August 3, 2020 5:14 AM EDT Send to a Friend
(Updated - August 3, 2020 5:18 AM EDT)(updating comment)Goldman Sachs analyst Terence Flynn upgraded Merck (NYSE: MRK) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login